Загрузка...
Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials
We measured immunosuppression at myeloma diagnosis and assessed the impact on survival in 5826 UK myeloma trial patients. Polyclonal immunoglobulin levels were below normal in 85% of patients and above normal in only 0.4% of cases for IgA, 0.2% for IgM and no cases for IgG. Immunoparesis had a great...
Сохранить в:
| Опубликовано в: : | Leukemia |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group UK
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6087716/ https://ncbi.nlm.nih.gov/pubmed/29925902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41375-018-0163-4 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|